RGEN
Repligen Corporation
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$167.68
−1.14%Leverage
- Debt / equity
- 0.33x
- Net debt / equity
- 0.04x
- Debt / assets
- 0.23x
- Debt / EBITDA
- 5.67x
- Net debt / EBITDA
- 0.69x
Liquidity & coverage
- Current ratio
- 9.05x
- Quick ratio
- 7.64x
- Cash ratio
- 6.11x
- Interest coverage
- 2.95x
- EBITDA / interest
- 5.51x
- Working capital
- $1.1B
Cash & dividend
- FCF / debt
- 0.16x
- Cash flow / debt
- 0.20x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026